ADJUST: A Study on MDT Prognostication

NACompletedINTERVENTIONAL
Enrollment

323

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

April 13, 2021

Study Completion Date

April 13, 2021

Conditions
Terminal Illness
Interventions
OTHER

Advice from the PiPS-B14 prognostic tool

"Participants were informed that prognostic advice came from the PiPS-B14 prognostic tool. PiPS-B14 is a validated prognostic algorithm that has been shown to be as accurate as an agreed multi-professional survival estimate.~Participants were further informed that in a previous study the PiPS-B14 risk categories for predicting two-week survival were as accurate as a doctor's or a nurse's prediction."

OTHER

Advice from another clinician

"Participants were informed that prognostic advice came from another clinician.~Doctors were told that advice was from a nurse, whereas nurses or other types of HCPs were told that advice was from a doctor."

Trial Locations (1)

WC1E 6BT

University College London, London

All Listed Sponsors
lead

University College, London

OTHER

NCT04568629 - ADJUST: A Study on MDT Prognostication | Biotech Hunter | Biotech Hunter